104 related articles for article (PubMed ID: 30560590)
21. In silico high-throughput virtual screening and molecular dynamics simulation study to identify inhibitor for AdeABC efflux pump of Acinetobacter baumannii.
Verma P; Tiwari M; Tiwari V
J Biomol Struct Dyn; 2018 Apr; 36(5):1182-1194. PubMed ID: 28393677
[TBL] [Abstract][Full Text] [Related]
22. Identification of Novel Aurora Kinase A (AURKA) Inhibitors via Hierarchical Ligand-Based Virtual Screening.
Kong Y; Bender A; Yan A
J Chem Inf Model; 2018 Jan; 58(1):36-47. PubMed ID: 29202231
[TBL] [Abstract][Full Text] [Related]
23. Virtual medicinal chemistry: in silico pre-docking functional group transformation for discovery of novel inhibitors of botulinum toxin serotype A light chain.
O'Malley S; Sareth S; Jiao GS; Kim S; Thai A; Cregar-Hernandez L; McKasson L; Margosiak SA; Johnson AT
Bioorg Med Chem Lett; 2013 May; 23(9):2505-11. PubMed ID: 23545109
[TBL] [Abstract][Full Text] [Related]
24. A lysine-to-arginine mutation on NEDD8 markedly reduces the activity of cullin RING E3 ligase through the impairment of neddylation cascades.
Sui Y; Liu Y; Xu G
Biochem Biophys Res Commun; 2015 Jun; 461(4):653-8. PubMed ID: 25918018
[TBL] [Abstract][Full Text] [Related]
25. 2-(4-Chlorophenyl)-2-oxoethyl 4-benzamidobenzoate derivatives, a novel class of SENP1 inhibitors: Virtual screening, synthesis and biological evaluation.
Chen Y; Wen D; Huang Z; Huang M; Luo Y; Liu B; Lu H; Wu Y; Peng Y; Zhang J
Bioorg Med Chem Lett; 2012 Nov; 22(22):6867-70. PubMed ID: 23044371
[TBL] [Abstract][Full Text] [Related]
26. Improving virtual screening predictive accuracy of Human kallikrein 5 inhibitors using machine learning models.
Fang X; Bagui S; Bagui S
Comput Biol Chem; 2017 Aug; 69():110-119. PubMed ID: 28601761
[TBL] [Abstract][Full Text] [Related]
27. Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity.
Martin E; Mukherjee P; Sullivan D; Jansen J
J Chem Inf Model; 2011 Aug; 51(8):1942-56. PubMed ID: 21667971
[TBL] [Abstract][Full Text] [Related]
28. Virtual compound screening in drug discovery.
Stumpfe D; Ripphausen P; Bajorath J
Future Med Chem; 2012 Apr; 4(5):593-602. PubMed ID: 22458679
[TBL] [Abstract][Full Text] [Related]
29. [Selection of a melanine concentrating hormone receptor-1 (MCHR1) antagonists' focused library and its biological screening with AequoScreen].
Flachner B; Hajdú I; Dobi K; Lorincz Z; Cseh S; Dormán G
Acta Pharm Hung; 2013; 83(3):71-87. PubMed ID: 24369586
[TBL] [Abstract][Full Text] [Related]
30. Screening and In Vitro Evaluation of Potential Plasmodium falciparum Leucyl Aminopeptidase Inhibitors.
Chaudhary M; Singh V; Anvikar AR; Sahi S
Curr Comput Aided Drug Des; 2016; 12(4):282-293. PubMed ID: 27449897
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive 3D-QSAR and binding mode of BACE-1 inhibitors using R-group search and molecular docking.
Huang D; Liu Y; Shi B; Li Y; Wang G; Liang G
J Mol Graph Model; 2013 Sep; 45():65-83. PubMed ID: 24004830
[TBL] [Abstract][Full Text] [Related]
32. High-throughput virtual screening lead to discovery of non-peptidic inhibitors of West Nile virus NS3 protease.
Huang D
Methods Mol Biol; 2012; 819():615-23. PubMed ID: 22183561
[TBL] [Abstract][Full Text] [Related]
33. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
Islam MA; Pillay TS
J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
[TBL] [Abstract][Full Text] [Related]
34. Recent developments with metalloprotease inhibitor class of drug candidates for botulinum neurotoxins.
Kumar G; Swaminathan S
Curr Top Med Chem; 2015; 15(7):685-95. PubMed ID: 25751268
[TBL] [Abstract][Full Text] [Related]
35. Deneddylase 1 regulates deneddylase activity of the Cop9 signalosome in Drosophila melanogaster.
Kim K; Yoon J; Yim J; Kim HJ
Insect Sci; 2017 Feb; 24(1):27-34. PubMed ID: 26332639
[TBL] [Abstract][Full Text] [Related]
36. Etoposide-induced SENP8 confers a feed-back drug resistance on acute lymphoblastic leukemia cells.
Sun S; Cheng Y; Hou W; Yan Y; Meng T; Li H; Xiao N
Biochem Biophys Rep; 2024 Mar; 37():101650. PubMed ID: 38314144
[TBL] [Abstract][Full Text] [Related]
37. Discovery of new potential antimalarial compounds using virtual screening of ZINC database.
Ghasemi JB; Shiri F; Pirhadi S; Heidari Z
Comb Chem High Throughput Screen; 2015; 18(2):227-34. PubMed ID: 25543686
[TBL] [Abstract][Full Text] [Related]
38. Target mechanism-based whole-cell screening identifies bortezomib as an inhibitor of caseinolytic protease in mycobacteria.
Moreira W; Ngan GJ; Low JL; Poulsen A; Chia BC; Ang MJ; Yap A; Fulwood J; Lakshmanan U; Lim J; Khoo AY; Flotow H; Hill J; Raju RM; Rubin EJ; Dick T
mBio; 2015 May; 6(3):e00253-15. PubMed ID: 25944857
[TBL] [Abstract][Full Text] [Related]
39. Virtual screening of novel reversible inhibitors for marine alkaline protease MP.
Ji X; Zheng Y; Wang W; Sheng J; Hao J; Sun M
J Mol Graph Model; 2013 Nov; 46():125-31. PubMed ID: 24200527
[TBL] [Abstract][Full Text] [Related]
40. Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach.
Prabhu SV; Tiwari K; Suryanarayanan V; Dubey VK; Singh SK
Comb Chem High Throughput Screen; 2017; 20(3):255-271. PubMed ID: 28116998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
